We present the case of a 66-year-old woman with Hashimoto's thyroiditis, who showed extremely high concentrations of serum thyroglobulin (Tg). Serum Tg levels were markedly elevated following a slight elevation of serum thyrotropin (TSH) (22,000 ng/mL and 11.1 pU/mL, respectively). Although elevated concentrations of serum Tg declined concomitant with decrease of serum TSH one month later, Tg concentrations remained high (>948 ng/mL) even at normal or suppressed TSH levels. There was no evidence of massive thyroid tissue damage or thyroid tumor. To our knowledge, there have been no case reports of such high concentrations of serum Tg (>2 x 104 ng/mL) in the clinical course of Hashimoto's thyroiditis. Furthermore, we showed evidence that extremely high Tg levels could possibly influence the measurement of anti-Tg autoantibody using highly sensitive radioimmunoassays.
THYROGLOBULIN (Tg) is a normal constituent of serum detectable by radioimmunoassay in all normal subjects [1] . The levels are altered in a number of physiological and pathological conditions. Abnormal concentrations of Tg are frequently observed in association with thyroid diseases; elevated serum Tg concentrations may result from excess thyroidal stimulation, physical thyroid damage or abnormalities in the thyroid mass. Patients with chronic autoimmune thyroiditis would be expected to have high serum Tg concentrations because of chronic thyroid inflammation and/or elevated thyrotropin (TSH) levels characteristic of this condition [1] , but the levels of serum Tg rarely exceed 1000 ng/mL under normal TSH level [2, 3] At the same time, the exact mechanisms governing these phenomena have been poorly understood.
We described here a case of markedly elevated serum Tg associated with Hashimoto's thyroiditis without any apparent causes, such as severe intrathyroidal destruction, association of Tg producible tumor or large elevation of serum TSH. Possible mechanisms of Tg elevation were discussed.
Case report
A 66-year-old woman who has been suffering from primary hypothyroidism since 1977 when she was 46, was diagnosed as Hashimoto's thyroiditis based on the presence of diffuse goiter, positive anti-Tg and anti-microsome antibody tests measured by the hemagglutination assay, and the finding of iodine (131I)-scintigraphy, and mild hypothyroidism (T3i 1.38 ng/ 100 ml; T4, 5.7 ug/ 100 ml; and TSH, 7.6 uU/ml). She had been treated with 50 pg of levothyroxine sodium (T4). She was also regularly given a single daily dose of 15 mg prednisolone orally to control interstitial nephritis possibly due to Sjogren's syndrome. Her compliance with these drugs was good. In addition, she had hypertension, hyperlipidemia and hyperuricemia.
On May 14, 1977, she was admitted to Kyoto University Hospital for evaluation of cardiac function and control of the systemic edema.
On admission, she had no complaints. Her blood pressure was 154/86 mmHg.
A moderate-sized diffuse goiter with an elastic consistency was palpable without any tenderness or lymphadenopathy.
Her face was mildly edematous.
There were no abnormal findings in the chest, abdomen or neurological examinations.
Laboratory data
The laboratory findings of the patient on admission demonstrated a mild leucocytosis, hyperuricemia (8.8 mg/100 ml). Total cholesterol was increased (total cholesterol 367 mg/100 ml). Indices of renal function revealed renal insufficiency (creatinine 2.9 mg/ 100 ml, blood urea nitrogen 56 mg/ 100 ml), and anti-hepatitis C virus antibody (HCV) was positive though of unclear etiology. Although serum Creactive protein (CRP) was not noticeably increased, erythrocyte sedimentation rate (ESR) was slightly accelerated (34 mm/hr). Data obtained from immunological examinations on admission were compatible with Sjogren's syndrome. Interstitial nephritis was diagnosed based on increased urine 3-microglobulin (5264pg/day) and al-microglobulin (81.9 fig/day) levels, and impaired urine concentration function. Renal biopsy was not performed because only the left kidney remained after right nephrectomy at age 25 due to renal tuberculosis.
Thyroidal function tests on admission (Table 1 ) showed a slightly decreased T3 level (44 ng/ 100 ml), though both serum free thyroxine (FT4) and triiodine thyronine (FT3) were within normal range under replacement therapy with 50 ig of levothyroxine sodium. Serum Tg level on admission was already extremely high at 2851 ng/100 ml (Ab Bead Thyroglobulin `Eiken', Eiken Co. Ltd., Tokyo, Japan; see also Fig. 1 ). Anti-thyroid peroxidase An open biopsy has not been performed for ethical reasons. Changes in serum Tg and endocrinological parameters of the thyroid gland, such as TSH, FT4, and FT3 after admission, are illustrated in Figure 1 . Serum Tg rose to very high levels following the elevation of TSH, probably due to the pause in medication for examinations of gastrointestinal fiberscopy for several days after admission. Elevated Tg levels fell following the decline of TSH level after resuming administration of T4, but still remained extremely high even at normal or suppressed TSH levels ( Fig. 1) .
To examine the abnormalities in iodine transport, radioactive iodine (123I) uptake was performed and counted at 3 and 24 hours after administration. Results were apparently low at 0.5% (3 h) and 1.4%
(24 h), probably due to suppressed TSH secretion (< 0.16 ,uU/ml) after replacement therapy with levothyroxine sodium. Perchlorate discharge test could not be performed because of the low iodine uptake.
A TRH-test was also performed to examine the acute effects of TSH on Tg release. No effects of TSH on Tg level were observed within 3 hrs after TRH administration, although TSH responses to TRH were slightly weak and delayed (Table 1) . Table 2 .
Tg determinations by other kits using the serum of May 27, 1997 To eliminate the possibility of artifacts in Tg measurements, we at first tested the reproducibility of Tg values and the existence of human anti-murine antibodies (HAMA). Repeated Tg determinations using the same kit confirmed the reproducibility, and the determinations by other kits using the serum of May 27, 1997 gave similar values (Table 2 ). Dilution test gave good recovery rates (Table 3) . No HAMA was detected (data not shown).
Next, we examined whether the Tg of the patient was of a native form or not, since heterogeneity is a key feature of Tg and Amounts of 123I-control Tg and 1231-IgG were measured by counting the radioactivities. (Fig. 2) . Thus, abnormal-sized molecules, at least fragmented ones, were not detected in the patient Tg.
It has been known that anti-Tg autoantibodies in sera influence Tg measurements by the RIA of double antibody method [6] . However, this effect is much less in the kit of Ab Bead Thyroglobulin `Eiken', since the monoclonal anti-Tg antibody used in this kit does not cross-react markedly with the autoantibodies.
Kasagi et al. reported that the autoantibodies, whose titer is less than a thousand fold in the hemagglutination test or 70 U/mL in RIA, hardly influence Tg measurements by this kit [7] . Since the autoantibody of this patient was at a negative or low level in RIA, it may be assumed that this kit gave accurate Tg values in this patient.
On the contrary, to detect the influence of high levels of Tg on the assay of anti-Tg antibody, we tested if the addition of various amounts of Tg affected the titers of anti-Tg antibodies.
Various amounts of Tg were added to reference sera with a low, mild or high titer of anti-Tg (Table 4) . In all of the reference sera, the higher the amount of Tg added to the serum, the lower the titer of Tg antibodies in the assay (Tg antibody kit `Eiken', Eiken Chemical Co., Ltd.).
Even the lower concentration of Tg (12,500 ng/mL) than the peak level of this patient (22,000 ng/mL) gave a false-negative result to a serum with a low titer of anti-Tg. These results suggested that the titrations of patient anti-Tg antibodies determined by this assay or by another radioimmunoassay (Thyroglobulin Antibody Direct Assay Kit, RSR Ltd.) were likely to be underestimated. This may be explained by the TSH stimulatory actions to the production of Tg which are thought to be different among cases. Supporting this speculation, there is a report that in some patients the Tg levels paralleled those of TSH behavior, while in others the TSH-Tg correlation was not so obvious [9] .
Since Tg concentrations of this patient remained high even in the absence of increased TSH level, factors other than TSH or thyroid damage might be considered to influence the Tg level. However, the indices of renal function remained unchanged throughout this period, suggesting that renal insufficiency was unlikely to be one of the major factors raising her serum Tg. In Hashimoto's thyroiditis, when the presence of anti-Tg antibodies, the concentration of serum Tg is expected to decrease [6] . It is, however, unlikely in the Tg measurement of this patient using the Tg assay kit (Ab Bead Thyroglobulin `Eiken', Eiken Chemical Co., Ltd.) in which monoclonal anti-Tg antibodies do not cross-react markedly with anti-Tg autoantibodies [7] . Conversely, very high levels of Tg may affect the assay of anti-Tg antibodies [13, 14] . Ohtaki and Endo previously showed that the effects of Tg on the assay of anti-Tg antibodies could be observed if the ratio of Tg to anti-human Tg antibodies were higher than 1:10 [13]. In fact, as shown in Table 4 , these observations appear still to be true in antibody titers measured by the highly sensitive Tg antibody kit `Eiken' and also in those of this patient measured by Thyroglobulin Antibody Direct Assay Kit (RSR Ltd.) In summary, this is, as far as we know, the first report of a patient with Hashimoto's thyroiditis who showed extremely elevated serum Tg levels during the clinical course. Because the causes and mechanisms of elevation of serum Tg with Hashimoto's thyroiditis remain to be clarified, this unusual case should be studied further.
